v3.25.2
Segmentation - Schedule of Company’s Segment Results (Details) - Operating Segments [Member] - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Condensed Statement of Income Captions [Line Items]    
Sales, net $ 141,760 $ 9,072,130
Cost of goods sold 83,290 466,802
Gross profit 58,470 8,605,328
Operating Expenses:    
Product development 1,373,351 693,448
Sales and marketing 811,537 215,332
General and administrative (A) 19,171,965 17,238,184
Transaction costs including those incurred with contingent Earn-out Share Liability 55,038,544
Depreciation and amortization 273,772 818,203
Impairment on investment 216,278  
Stock-based compensation 6,699,081  
Inventory impairment 551,492  
Other income, net (21,390) 59,982
UK R&D tax credit (1,251,243)
Loss on initial issuance of convertible note 1,770,933
Change in fair value of convertible note option liability (840,933)
Change in fair value of warrant liabilities (200,124)
Change in fair value of Earn-out Share Liability (38,040,000)
Other expense 244,732 (21,857)
Interest income 1,942
Interest expense 1,808,243 (5,318,817)
Segment and Consolidated Net loss $ (47,547,768) $ (15,638,589)